Multiple resistance to macrocyclic lactones in the sheep scab mite Psoroptes ovis.
Acariasis
Disease
Mange
Parasite
Journal
Veterinary parasitology
ISSN: 1873-2550
Titre abrégé: Vet Parasitol
Pays: Netherlands
ID NLM: 7602745
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
08
05
2019
revised:
23
07
2019
accepted:
25
07
2019
entrez:
10
8
2019
pubmed:
10
8
2019
medline:
7
9
2019
Statut:
ppublish
Résumé
The astigmatid mite Psoroptes ovis (Acari: Proroptidae) causes the highly contagious and debilitating ovine disease, sheep scab. This ectoparasitic infection has a high economic and animal welfare impact on British sheep farming. Following recent work demonstrating resistance of Psoroptes mites to moxidectin, a widely used macrocyclic lactone (ML) treatment for scab, the current study compared the toxicity of three of the commonly administered macrocylic lactone therapeutic treatments (moxidectin, ivermectin and doramectin) to P. ovis from outbreak populations that had appeared unresponsive to treatment. These outbreak populations were from Wales and south west England. The data presented demonstrate that there is resistance to all three available ML compounds in populations of Psoroptes mites. However, considerable variation in response suggested that resistance alone was not responsible for the reported lack of efficacy in all of the submitted cases; lack of response in others may be associated with inappropriate treatment application or management. These data highlight the importance of the appropriate use of these compounds to manage national scab incidence at levels that are consistent with acceptable animal welfare standards, while attempting to reduce the development and spread of resistance.
Identifiants
pubmed: 31395209
pii: S0304-4017(19)30170-0
doi: 10.1016/j.vetpar.2019.07.007
pii:
doi:
Substances chimiques
Antiparasitic Agents
0
Lactones
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
79-82Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.